Glyscend study reveals metabolic benefits of its oral polymer-based duodenal exclusion therapyGlyscend has presented data from a study of its proprietary oral polymer duodenal exclusion therapy, at the American Diabetes Association...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure2 days ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity2 days ago